ALERT-HFAdherence to Chronic Heart Failure Treatment Guidelines Evaluation
This study aims to observe how well patients with chronic heart failure adhere to their treatment guidelines, specifically looking at the use of ACEI, ARB, beta blockers, loop diuretics, aldosterone antagonists, digoxin, anticoagulant therapy, and implantation of cardiac devices.
Data Collection
Collected at a single point in time - Cross-sectionalCase-Only
Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.Summary
Study start date: November 1, 2012
Actual date on which the first participant was enrolled.This study, ALERT-HF, focuses on individuals living with chronic heart failure. Its main goal is to assess how well doctors follow current treatment guidelines when caring for these patients. The study also aims to understand the criteria used for diagnosing chronic heart failure. It's important because it can help identify areas for improvement in patient care and ensure that everyone receives the best possible treatment. The study is observational, meaning it involves watching and recording what happens without any direct intervention. During the study, the number of patients receiving specific treatments will be recorded. These treatments include ACEI, ARB, beta blockers, loop diuretics, aldosterone antagonists, digoxin, anticoagulant therapy, and the implantation of cardiac devices. These are all common treatments for chronic heart failure. By tracking how often these treatments are used, the study can provide insights into how closely current treatment guidelines are being followed. The study doesn't involve any new treatments or procedures, it simply observes and records the care that patients are already receiving.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.660 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-only
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
ARCA Campania healthcare ambulatories
Naples, ItalyOpen ARCA Campania healthcare ambulatories in Google Maps